Immunomedics Inc.

(IMMU) Trade

By |

Profile

Immunomedics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.

Contact Information

Website: www.immunomedics.com
Email: investor@immunomedics.com
Main Phone: +1 973 605-8200
Address: 300 The American Road
State: NJ
City / Town: Morris Plains
Country: USA
Postal Code: 07950

Issuer Information

Exchange: NSD
CEO: Michael F. Pehl
Employees: 138
NAICS: In-Vitro Diagnostic Substance Manufacturing (325413)
$ 25.58 $ 0.65 (2.61%)
Last Price 25.58 Change $ 0.65 Change % 2.61 Tick N/A
Bid 25.12 Bid Size 10,000.00 Ask 26.00 Ask Size 100.00
Open 24.99 High 25.72 Low 24.82 Prev Close 24.93
Last Trade Volume 1.3 mi 52 Wk Hi 26.48 52 Wk Low 7.17
Market Cap 4.6 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 180,571,526.00 EPS (TTM) -1.70 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 36
Number of Buys 0 9
Number of Sells 0 27
Net Activity 0 6155861
Last 10 Buys Shares
Behzad Aghazadeh 1,000
Behzad Aghazadeh 1,000
Last 10 Sell Shares
David M. Goldenberg 1,000
David M. Goldenberg 1,000
David M. Goldenberg 1,000
David M. Goldenberg 1,000
David M. Goldenberg 1,000
David M. Goldenberg 1,000
Brian A. Markison 1,000
David M. Goldenberg 1,000
David M. Goldenberg 1,000
David M. Goldenberg 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 31 25 25 53
Low Target Price Estimate 20 20 20 22
Mean Target Price Estimate 24.33 22.33 22.33 34
Standard Deviation 5.86 2.52 2.52 13.29
Date of Most Recent Estimate 06/04/18 05/21/18 05/10/18 06/07/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1